The Rosa26-RRAS2fl/flxmb1-Cre mouse line reported in [46] is a novel model of B-CLL where the leukemic CD19+CD5+ cells appear early in the life of mice. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.